ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Mississippi » Pulmonary Disease

Top Pulmonary Disease Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FREDERICK DUGGAN M.D.

Pulmonary Disease

12,515

$806K

791
613 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 53%

$64
Average prescription price

Avg: $137

WILLIAM REID M.D.

Pulmonary Disease

12,297

$602K

506
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 53%

$49
Average prescription price

Avg: $137

EDWARD HOLMES M.D.

Pulmonary Disease

5,835

$355K

376
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 53%

$61
Average prescription price

Avg: $137

LANCE BUSCH D.O.

Pulmonary Disease

5,681

$447K

345
190 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

26%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 53%

$79
Average prescription price

Avg: $137

SUSAN TAYLOR M.D.

Pulmonary Disease

4,972

$1.09M

243
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 53%

$219
Average prescription price

Avg: $137

BRODIE MCALPIN M.D.

Pulmonary Disease

4,442

$539K

536
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 53%

$121
Average prescription price

Avg: $137

KARY WHITEHEAD M.D.

Pulmonary Disease

4,243

$410K

398
293 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 53%

$97
Average prescription price

Avg: $137

RICHMOND ALEXANDER M.D.

Pulmonary Disease

3,665

$332K

397
288 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 53%

$91
Average prescription price

Avg: $137

KIMBERLY DOBBS M.D.

Pulmonary Disease

3,005

$415K

390
287 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 53%

$138
Average prescription price

Avg: $137

ROBERT STEWART MD

Pulmonary Disease

2,741

$667K

375
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 53%

$243
Average prescription price

Avg: $137

JAMES RISH MD

Pulmonary Disease

2,479

$405K

298
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 53%

$164
Average prescription price

Avg: $137

DAVID WITTY MD

Pulmonary Disease

2,303

$331K

363
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 53%

$144
Average prescription price

Avg: $137

STEVEN STOGNER MD

Pulmonary Disease

2,270

$246K

328
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 53%

$109
Average prescription price

Avg: $137

WILLIAM EDMONSON MD

Pulmonary Disease

1,976

$259K

336
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 53%

$131
Average prescription price

Avg: $137

AMAN MUNIR M.D.

Pulmonary Disease

1,938

$348K

246
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 53%

$180
Average prescription price

Avg: $137

WALID YOUNIS MD

Pulmonary Disease

1,898

$422K

264
177 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 53%

$222
Average prescription price

Avg: $137

DAVID REED D.O.

Pulmonary Disease

1,875

$357K

246
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 53%

$190
Average prescription price

Avg: $137

PAUL PERRY MD

Pulmonary Disease

1,776

$319K

265
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 53%

$180
Average prescription price

Avg: $137

LYNDON PERKINS MD

Pulmonary Disease

1,744

$176K

242
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 53%

$101
Average prescription price

Avg: $137

LEWIS NEESE MD

Pulmonary Disease

1,715

$280K

241
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 53%

$163
Average prescription price

Avg: $137

WILLIAM WILLIAMS MD

Pulmonary Disease

1,699

$252K

225
177 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 53%

$148
Average prescription price

Avg: $137

JANICE MILES DO

Pulmonary Disease

1,636

$225K

263
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 53%

$137
Average prescription price

Avg: $137

JAIME UNGO MD

Pulmonary Disease

1,608

$285K

275
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 53%

$177
Average prescription price

Avg: $137

OLUKUNLE AJAGBE MD

Pulmonary Disease

1,485

$165K

233
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 53%

$111
Average prescription price

Avg: $137

BARRY WHITES MD

Pulmonary Disease

1,476

$191K

180
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 53%

$129
Average prescription price

Avg: $137

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank